To better understand the mechanism of PAX3 as an oncosuppressor in thyroid cancer, we tested the effect of PAX3 re-expression on the PI3K/Akt and MAPK cascades in thyroid cancer cells. This evidence concerns the gene AKT1 and thyroid cancer.